Search
for
Sort by
Research 751–780 of 1000+
- Regulation of Semaphorin3A in the process of cutaneous wound healing
- Diseases on Hair Follicles Leading to Hair Loss Part I: Nonscarring Alopecias
- New treatments for rheumatoid arthritis
- COVID-19 infection leading to acute pustular dermatoses
- Utilizing Electromagnetic Radiation for Hair Growth
- Retinoids for Chemoprophylaxis of Nonmelanoma Skin Cancer
- 25 years of ERβ: a personal journey
- The Potential Relevance of the Microbiome to Hair Physiology and Regeneration: The Emerging Role of Metagenomics
- Dermatoscopic findings of syphilitic alopecia
- The developing immune network in human prenatal skin
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
- Alopecia Areata, Primary Sclerosing Cholangitis, and Ulcerative Colitis: Autoimmunity and Apoptosis as Common Links?
- Perspectives in dermatopathology: telomeres and telomerase in ageing and cancer; with emphasis on cutaneous disease
- Immunomodulators in the treatment of cutaneous lymphoma
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Common Dermatologic Disorders in Down Syndrome: Systematic Review
- Can plant‐derived phytochemicals provide symptom relief for hair loss? A critical review
- Pathophysiology of the Burn Scar
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Acquired immunogenicity of DNA after modification with malondialdehyde in patients with alopecia areata
- Association of vitamin D level with alopecia areata
- Diseases that turn African hair silky
- Ketoconazole Shampoo for Seborrheic Dermatitis of the Scalp: A Narrative Review
- Human placenta hydrolysates: from V.P. Filatov to the present day: Review
- Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney
- Cancer risk by the subtype of alopecia
- Novel therapies for alopecia areata: The era of rational drug development
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Multiple minute digitate hyperkeratosis